xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">
http://www.cdc.gov/mmwr//preview/mmwrhtml/00017686.htm
<>
October 02, 1992 / 41(39);721-722
Tetanus -- Rutland County, Vermont, 1992
In July 1992, the Vermont Department of Health received a report of a case
of tetanus. The last reported case of tetanus in Vermont was in 1987. This
report summarizes the case investigation.
On July 12, a 31-year-old woman with left-sided face pain visited the
emergency department of the hospital in Rutland. She was unable to open her
mouth because of facial muscle spasms and had been unable to eat for 3-4 days
because of severe pain and tightness of the jaw. Her attending physician noted
trismus and risus sardonicus. She reported that on about July 5 she had walked
barefoot in her garden and incurred a puncture wound at the base of her right
great toe; she cleaned the wound and removed a few small pieces of wood but did
not seek medical attention. On July 8, she had sought medical care from her
primary-care physician for severe left-sided facial tightness and pain. She was
treated with amoxicillin for presumptive sinusitis, but her condition worsened.
A presumptive diagnosis of tetanus was made in the emergency department, and
the patient was admitted to the hospital. When the case was reported to the
state health department, the patient's vaccination records were examined.
School records indicated that she had been vaccinated with diphtheria and
tetanus toxoids vaccine (DT) at ages 6 years 3 months, 6 years 5 months, and 8
years 3 months. Although she recalled receiving a tetanus booster at age 14
years, this could not be confirmed by school records or her physician.
On the basis of her clinical presentation and tetanus vaccination history,
she was given tetanus toxoid, 3250 IU of tetanus immune globulin, and
intravenous penicillin. Her puncture wound was thoroughly debrided; several
additional small pieces of wood were removed. Although she was treated for
muscle spasm, mechanical ventilation was not required. At the time of discharge
15 days later, she had difficulty performing simple tasks, such as tying
shoelaces.
Reported by: S Brittain, MD, M Stickney, MD, Rutland Regional Medical
Center, Rutland; M Terkla, M Segale, L Paulozzi, MD, R Houseknecht, PhD, State
Epidemiologist, Vermont Dept of Health. Div of Field Epidemiology, Epidemiology
Program Office; Div of Immunization, National Center for Prevention Svcs, CDC.
Editorial Note
Editorial Note: Tetanus is a clinical diagnosis based on acute onset of
hypertonia and/or painful muscular contractions (usually of the muscles of the
jaw and neck) and generalized muscle spasms without other apparent medical
cause (as reported by a health professional) (1). Tetanus is caused by
tetanospasmin, an exotoxin produced by Clostridium tetani spores, which are
ubiquitous in the environment and enter the body usually through a wound;
proliferation of bacilli under anaerobic conditions results in the production
of tetanospasmin.
Worldwide, tetanus is a problem among nonimmunized or underimmunized
persons. In developing countries, where aseptic perinatal care and vaccination
programs may not reach all risk groups, tetanus is one of the most important
causes of neonatal mortality (2). In comparison, tetanus has become rare in the
United States. Universal childhood vaccination with diphtheria and tetanus
toxoids and pertussis vaccine (DTP) and widespread use of tetanus toxoid
combined with improved wound management have resulted in a decrease in tetanus
reported in the United States from 560 cases in 1947 (when national
surveillance began) to 57 cases in 1991 (3). Only one case of neonatal tetanus
was reported to CDC during 1985- 1991 (CDC, unpublished data, 1992).
Tetanus toxoid is a highly effective vaccine. Protective levels of serum
antitoxin are generally maintained for at least 10 years in properly vaccinated
persons (4). After completion of a primary vaccination series, booster doses of
tetanus toxoid combined with diphtheria toxoid (as Td) every 10 years are
recommended by the Advisory Committee on Immunization Practices (4). Although
the patient described in this report had received a complete primary series of
tetanus vaccinations, there was no record indicating she had received booster
doses.
Of the 109 tetanus patients for whom complete information was available for
1989 and 1990, 94% were aged greater than or equal to 20 years (CDC,
unpublished data, 1992). Older persons are at greater risk for developing
tetanus because many have never been vaccinated with a primary series of
tetanus toxoid or with booster doses of tetanus toxoid. In 1989 and 1990, of
the 57 persons with tetanus and known vaccination status, 45 (79%) had received
fewer than three doses of DTP. Another eight (14%) persons had not received a
booster dose in the 10 years preceding onset of illness (CDC, unpublished data,
1992).
Wounds such as that of the patient described in this report are common,
especially during the summer months. Often such wounds are judged to not
warrant a physician or emergency room visit. Establishment and maintenance of
adequate tetanus antitoxin levels by administration of primary vaccination and
routine booster vaccinations are the only means to avert tetanus. Internists,
family practitioners, and other primary health-care providers who treat adults
should use every opportunity to review the vaccination status of their patients
and administer required vaccines.
References
1.
CDC. Case definitions for public health surveillance. MMWR
1990;39(no. RR-13):38.
2.
Cate TR. Clostridium tetani (tetanus). In: Mandell GL, Douglas
RG, Bennett JE, eds. Principles and practice of infectious diseases. 3rd ed.
New York: Churchill Livingstone Inc, 1990:1842-6.
3.
CDC. Final 1991 reports of notifiable diseases. Notifiable
diseases -- reported cases, by geographic division and area, United States,
1991. MMWR 1992;41:631,638.
4.
ACIP. Diphtheria, tetanus, and pertussis: recommendations for
vaccine use and other preventive measures -- recommendations of the
Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(no. RR-10):2-8.
All MMWR HTML documents published
before January 1993 electronic conversions from ASCII text into HTML. This
conversion may have resulted in character translation or format errors in the
HTML version. Users should not rely on this HTML document, but are referred to
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of
Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371;
telephone: (202) 512-1800. Contact GPO for current prices.
Return To:
MMWR
MMWR
Home Page CDC Home Page
**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.
Page converted: 08/05/98
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.